Life Sciences Artificial Intelligence (AI) Market By Type 2024 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Life Sciences Artificial Intelligence (AI) Market
Life Sciences Artificial Intelligence (AI) Market: By Type (Machine Learning (ML), Deep Learning (DL), Neural Networks (NN)); By Three-Wave Process (First Wave, Second Wave, Third Wave); By Application (Discovery, Pre – Clinical, Clinical, Regulatory Approval, and Patients); By Geography - Forecast(2018-2024)
Report Code : ITR 0175
Updated Date: 21 May, 2018  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Life Sciences AI Market Overview
2. Executive Summary
3. Life Sciences AI Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. Life Sciences AI Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Life Sciences AI – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Life Sciences AI – Regulatory Analysis
7. Life Sciences AI Market - By Type
   7.1. Introduction
   7.2. Machine Learning
      7.2.1. Diagnosis and Disease Identification
      7.2.2. Personalized Medicine
      7.2.3. Drug Discovery 
      7.2.4. Clinical Trials
      7.2.5. Radiotherapy and Radiology
      7.2.6. Electronic Health Records
      7.2.7. Others
   7.3. Deep Learning
   7.4. Neural Networks
8. Life Sciences AI Market - By process
   8.1. Introduction
   8.2. First Wave
   8.3. Second Wave
   8.4. Third Wave
9. Life Sciences AI Market - By End-User Application
   9.1. Introduction
   9.2. Drug Discovery
      9.2.1. Identify Unmet Medical Needs
      9.2.2. Target Identification
      9.2.3. Target Validation
      9.2.4. Assay Development to Identify Models
      9.2.5. Lead Identification
      9.2.6. Lead Optimization
      9.2.7. Safety/Efficacy Studies
   9.3. Pre -Clinical 
      9.3.1. In Vitro Studies
      9.3.2. In Vivo Studies
      9.3.3. Pharmacokinetic Studies 
      9.3.4. Absorption, Distribution, Metabolism, Excretion (ADME) Studies
      9.3.5. Formulation Delivery, Packaging Development
      9.3.6. Investigation New Drug (IND) Process
   9.4. Clinical
      9.4.1. Design Trails
      9.4.2. Patient Identification
      9.4.3. Patient Enrollment
      9.4.4. Execution of Trails
      9.4.5. Data Collection & Analytics
   9.5. Drug Approval
      9.5.1. Data Reporting
      9.5.2. Approval of Application and Process
      9.5.3. Labeling
      9.5.4. Safety Updates
      9.5.5. FDA Approval
   9.6. Patient Monitoring
      9.6.1. Preventive Medicine
      9.6.2. Personalized Medicine
      9.6.3. Beyond the Bill
      9.6.4. Patient Identification
      9.6.5. Patient Engagement
      9.6.6. Disease Diagnosis & Management
   9.7. Others
      9.7.1. Diagnosis & Disease Identification
      9.7.2. Personalized Medicine
      9.7.3. Electronic Health Records
10. Distance Measurement Sensor Market - By Geography
   10.1. North America
      10.1.1. U.S.
      10.1.2. Canada
      10.1.3. Mexico
   10.2. South America
      10.2.1. Brazil
      10.2.2. Argentina
      10.2.3. Chile
      10.2.4. Rest of South America
   10.3. Europe
      10.3.1. U.K.
      10.3.2. Germany
      10.3.3. Italy
      10.3.4. France
      10.3.5. Nordic
      10.3.6. Russia
      10.3.7. Eastern Europe
      10.3.8. Switzerland
      10.3.9. Belgium
      10.3.10. Rest of Europe
   10.4. APAC
      10.4.1. Japan
      10.4.2. China
      10.4.3. India
      10.4.4. South Korea
      10.4.5. Taiwan
      10.4.6. Southeast Asia
      10.4.7. Australia
      10.4.8. New Zealand 
      10.4.9. Rest of APAC
   10.5. ROW
      10.5.1. Middle East
            10.5.1.1. Saudi Arabia 
            10.5.1.2. U.A.E
            10.5.1.3. Qatar
            10.5.1.4. Rest of Middle East
      10.5.2. Africa
            10.5.2.1. South Africa
            10.5.2.2. Nigeria
            10.5.2.3. Egypt
            10.5.2.4. Rest of Africa
11. Market Entropy
   11.1. New Product Launches
   11.2. M&As, Collaborations, JVs, Partnership
12. Company Profiles
   12.1. TwoXAR
   12.2. Numerate
   12.3. NuMedii
   12.4. IBM
   12.5. Envisagenics
   12.6. Company 6
   12.7. Company 7
   12.8. Company 8
   12.9. Company 9
   12.10. Company 10
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
13. Appendix
   13.1. Abbreviations
   13.2. Sources
   13.3. Research Methodology
   13.4. Bibliography
   13.5. Compilation of Expert Insights
   13.6. Disclaimer
The Life Sciences AI Market is estimated to surpass $239.1 million by 2024, growing at an estimated rate of 14% from 2018 to 2024. The AI in life science industry is majorly driven by the efforts put to develop automation systems, among others. Growing interests towards artificial intelligence is also set to propel the market growth in the future.

Currently, Artificial Intelligence (AI) is in the growing stage, but it is showing significant growth in life sciences industry in the upcoming future due to rising application in initiating drug discovery and enhancement. As, Life Sciences are full of high-end processes, Artificial Intelligence is used to manage, gather and very nicely utilize all the structured and unstructured data.

Implementing artificial intelligence with life sciences industry is growing rapidly, and now with the chance to transfer old processes over discovery, enhancement, manufacturing and regulation, to take medicines immediately to the patients. Very tough drug discovery and computational bio and chemistry modeling influenced by AI, hold significant potential to deliver early insights into the workings of the drugs. This will automatically enhance business performance and downstream effort.

Mainly, lengthy and high cost enhancement processes is the main area where artificial intelligence can be influenced to augment trail managers to effectively manage typical global operations, trail designing and planning, risk predictions, examining and CAPA, and to gain significant efficiencies. Artificial intelligence  has faced rising adoption as it reduces time and costs. These technologies however are yet to be significantly adapted in the Asia Pacific region.

This report incorporates an in-depth assessment of life sciences AI market by type namely, three-wave process, end-user applications and geography. The major terms in life sciences AI encompassed in the scope includes various diagnosis and disease identification, personalized medicine, drug discovery and manufacture, clinical trials, radio therapy and radiology, and electronic health records.

What are the major applications for Life Sciences AI?
The various end users assessed include drug discovery, pre-clinical, clinical, drug approval, patient monitoring and others. A broad range of asset tracking applications in faster drug discovery which are currently being explored includes many safety precautions, and target identifications, which are raising the market of the Life Sciences AI, and estimated to have huge growth during the forecast period. The capital expenditure of major companies in the discovery of diseases and safety measures have also escalated significantly since the last decade.



Market Research and Market Trends of Life Sciences AI
  • In upcoming future, the main goal is to introduce the most impacted trends which are affecting the market of the AI in the life sciences industry.
  • As, the technology is in advanced position, the trends related to AI-powered drug discovery in the life sciences industry are getting a very less similar responses. The following are the main trends which leads AI to emerge in life sciences.
  • What can be automated, will be automated - initially, there were several steps of drug discovery which are very expensive to perform, which took time and were labor demanding. If pharmaceutical companies starts different stages along with automation automatically it will save money, time and rises success rates
  • Unified Machine Learning Models – Building Unified Models will support the estimation of future behavior of compounds and their performance in confused clinical trials. Mainly, there are 2 stages which are accessible: estimating toxicity and estimating efficacy of combined therapies.
  • Lack of AI-Skilled Labor – Many high-skilled and also very talented AI developers are willing to work with the life sciences industry. The life sciences industry will not only be attractive, but also very interesting, and the developers who worked with this industry will become new entrepreneurs.
  • Commodification of the Data – There is an option of many regular public data sets like PubMed, Clinicaltrials.gov, and US patent office filling data. These had been resolved by AI companies, making the data set, mainly interchangeable. Some companies with their investments in the quality of modification of these data sets are dispersing themselves and also in their ability to fix at a time orthogonal data sets like genomic or expression data.
  • Table Stakes – Now, it is fully estimated that a vendor will be performing some aspect of machine learning to their data or services. Table stakes are taking place many times in pharmaceutical research as well, especially in computer vision and automated tasks. The variation should not be there that AI is being applied, but how well it is being applied.
  • Startups and tech companies take the lead in AI-Powered Drug Discovery – Growing internal experiences in deep learning and reinforcement learning is very tough as the expert scientists are showing interest in achieving the results very faster, and also very few deep leaning experts with too much intelligence in biomedical sciences.
  • Big Pharmaceutical Companies switch from partnerships to acquisitions – In 2017, almost each and every big pharmaceutical company announced a partnership with one or more AI startups. 
  • China takes the lead – China is the leading country which is developing greatly in the AI sector, when compared to other countries because of high investments in the field and heavy interest with a high population. 
  • Adapting AI talent in China has now become very costly, and there are many pharmaceutical companies which were looking forward to incorporate AI in drug discovery. And also, it became mandatory for the executives to get an international outlook of the AI industry, looking beyond the most similar hubs such as Boston and Silicon Valley.

Who are the Major Players in Life Sciences AI?
Some of the major companies included in the report areTwoXAR, Numerate, NuMedii, IBM, and Envisagenics.

What is our report scope?
The report incorporates in-depth assessment of the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis and so on, to gauge the impact forces and potential opportunities of the market. Apart from this, the report also includes a study of major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers and so on, to comprehend the prevailing market dynamics at present, and its impact during the forecast period 2018-2024.

All our reports are customizable to as per the company needs, to a certain extent, we do provide 20 free consulting hours along with the purchase of each report, this which will allow you to request any additional data to customize the report to as per your needs.

Key Takeaways from this Report
  • Evaluate market potential by analyzing growth rates (CAGR %), Volume (Units) and Value ($Million) of the data given at country level – for product types, end use applications and for different industry verticals.
  • Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
  • Get in-depth insights on your competitor’s performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
  • Analyze the sales and distribution channels across key geographies to improve top-line revenues.
  • Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and to increase the efficiency your processes. 
  • Get a quick outlook of the market entropy – M&As, deals, partnerships, product launches of all key players for the past 4 years. 
  • Evaluate the supply-demand gaps, import-export statistics, and regulatory landscape for more than top 20 countries globally, for the market. 
List of Tables

Table 1: Life Sciences Artificial Intelligence (AI) Market Overview 2017-2023
Table 2: Life Sciences Artificial Intelligence (AI) Market Leader Analysis 2017-2018 (US$)
Table 3: Life Sciences Artificial Intelligence (AI) Market Product Analysis 2017-2018 (US$)
Table 4: Life Sciences Artificial Intelligence (AI) Market End User Analysis 2017-2018 (US$)
Table 5: Life Sciences Artificial Intelligence (AI) Market Patent Analysis 2013-2018* (US$)
Table 6: Life Sciences Artificial Intelligence (AI) Market Financial Analysis 2017-2018 (US$)
Table 7: Life Sciences Artificial Intelligence (AI) Market Driver Analysis 2017-2018 (US$)
Table 8: Life Sciences Artificial Intelligence (AI) Market Challenges Analysis 2017-2018 (US$)
Table 9: Life Sciences Artificial Intelligence (AI) Market Constraint Analysis 2017-2018 (US$)
Table 10: Life Sciences Artificial Intelligence (AI) Market Supplier Bargaining Power Analysis 2017-2018 (US$)
Table 11: Life Sciences Artificial Intelligence (AI) Market Buyer Bargaining Power Analysis 2017-2018 (US$)
Table 12: Life Sciences Artificial Intelligence (AI) Market Threat of Substitutes Analysis 2017-2018 (US$)
Table 13: Life Sciences Artificial Intelligence (AI) Market Threat of New Entrants Analysis 2017-2018 (US$)
Table 14: Life Sciences Artificial Intelligence (AI) Market Degree of Competition Analysis 2017-2018 (US$)
Table 15: Life Sciences Artificial Intelligence (AI) Market Value Chain Analysis 2017-2018 (US$)
Table 16: Life Sciences Artificial Intelligence (AI) Market Pricing Analysis 2018-2023 (US$)
Table 17: Life Sciences Artificial Intelligence (AI) Market Opportunities Analysis 2018-2023 (US$)
Table 18: Life Sciences Artificial Intelligence (AI) Market Product Life Cycle Analysis 2018-2023 (US$)
Table 19: Life Sciences Artificial Intelligence (AI) Market Supplier Analysis 2017-2018 (US$)
Table 20: Life Sciences Artificial Intelligence (AI) Market Distributor Analysis 2017-2018 (US$)
Table 21: Life Sciences Artificial Intelligence (AI) Market Trend Analysis 2017-2018 (US$)
Table 22: Life Sciences Artificial Intelligence (AI) Market Size 2017 (US$)
Table 23: Life Sciences Artificial Intelligence (AI) Market Forecast Analysis 2018-2023 (US$)
Table 24: Life Sciences Artificial Intelligence (AI) Market Sales Forecast Analysis 2018-2023 (Units)
Table 25: Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 26: Life Sciences Artificial Intelligence (AI) Market By Type, Revenue & Volume, By Machine Learning, 2018-2023 ($)
Table 27: Life Sciences Artificial Intelligence (AI) Market By Type, Revenue & Volume, By Deep Learning, 2018-2023 ($)
Table 28: Life Sciences Artificial Intelligence (AI) Market By Type, Revenue & Volume, By Neural Networks, 2018-2023 ($)
Table 29: Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By process, 2018-2023 ($)
Table 30: Life Sciences Artificial Intelligence (AI) Market By process, Revenue & Volume, By First Wave, 2018-2023 ($)
Table 31: Life Sciences Artificial Intelligence (AI) Market By process, Revenue & Volume, By Second Wave, 2018-2023 ($)
Table 32: Life Sciences Artificial Intelligence (AI) Market By process, Revenue & Volume, By Third Wave, 2018-2023 ($)
Table 33: Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By End User Application, 2018-2023 ($)
Table 34: Life Sciences Artificial Intelligence (AI) Market By End User Application, Revenue & Volume, By Drug Discovery, 2018-2023 ($)
Table 35: Life Sciences Artificial Intelligence (AI) Market By End User Application, Revenue & Volume, By Pre -Clinical, 2018-2023 ($)
Table 36: Life Sciences Artificial Intelligence (AI) Market By End User Application, Revenue & Volume, By Clinical, 2018-2023 ($)
Table 37: Life Sciences Artificial Intelligence (AI) Market By End User Application, Revenue & Volume, By Drug Approval, 2018-2023 ($)
Table 38: Life Sciences Artificial Intelligence (AI) Market By End User Application, Revenue & Volume, By Patient Monitoring, 2018-2023 ($)
Table 39: North America Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 40: North America Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By process, 2018-2023 ($)
Table 41: North America Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By End User Application, 2018-2023 ($)
Table 42: South america Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 43: South america Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By process, 2018-2023 ($)
Table 44: South america Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By End User Application, 2018-2023 ($)
Table 45: Europe Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 46: Europe Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By process, 2018-2023 ($)
Table 47: Europe Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By End User Application, 2018-2023 ($)
Table 48: APAC Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 49: APAC Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By process, 2018-2023 ($)
Table 50: APAC Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By End User Application, 2018-2023 ($)
Table 51: Middle East & Africa Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 52: Middle East & Africa Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By process, 2018-2023 ($)
Table 53: Middle East & Africa Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By End User Application, 2018-2023 ($)
Table 54: Russia Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 55: Russia Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By process, 2018-2023 ($)
Table 56: Russia Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By End User Application, 2018-2023 ($)
Table 57: Israel Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 58: Israel Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By process, 2018-2023 ($)
Table 59: Israel Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By End User Application, 2018-2023 ($)
Table 60: Top Companies 2017 (US$)Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume
Table 61: Product Launch 2017-2018Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume
Table 62: Mergers & Acquistions 2017-2018Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume
List of Figures

Figure 1: Overview of Life Sciences Artificial Intelligence (AI) Market 2017-2023
Figure 2: Market Share Analysis for Life Sciences Artificial Intelligence (AI) Market 2017 (US$)
Figure 3: Product Comparison in Life Sciences Artificial Intelligence (AI) Market 2017-2018 (US$)
Figure 4: End User Profile for Life Sciences Artificial Intelligence (AI) Market 2017-2018 (US$)
Figure 5: Patent Application and Grant in Life Sciences Artificial Intelligence (AI) Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Life Sciences Artificial Intelligence (AI) Market 2017-2018 (US$)
Figure 7: Market Entry Strategy in Life Sciences Artificial Intelligence (AI) Market 2017-2018
Figure 8: Ecosystem Analysis in Life Sciences Artificial Intelligence (AI) Market 2017
Figure 9: Average Selling Price in Life Sciences Artificial Intelligence (AI) Market 2017-2023
Figure 10: Top Opportunites in Life Sciences Artificial Intelligence (AI) Market 2017-2018
Figure 11: Market Life Cycle Analysis in Life Sciences Artificial Intelligence (AI) Market Market Life Cycle Analysis in 3D Printing
Figure 12: GlobalBy TypeLife Sciences Artificial Intelligence (AI) Market Revenue, 2018-2023 ($)
Figure 13: GlobalBy processLife Sciences Artificial Intelligence (AI) Market Revenue, 2018-2023 ($)
Figure 14: GlobalBy End User Application Life Sciences Artificial Intelligence (AI) Market Revenue, 2018-2023 ($)
Figure 15: Global Life Sciences Artificial Intelligence (AI) Market - By Geography
Figure 16: Global Life Sciences Artificial Intelligence (AI) Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 17: Global Life Sciences Artificial Intelligence (AI) Market CAGR, By Geography, 2018-2023 (%)
Figure 18: North America Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 19: US Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 20: US GDP and Population, 2017-2018 ($)
Figure 21: US GDP – Composition of 2017, By Sector of Origin
Figure 22: US Export and Import Value & Volume, 2017-2018 ($)
Figure 23: Canada Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 24: Canada GDP and Population, 2017-2018 ($)
Figure 25: Canada GDP – Composition of 2017, By Sector of Origin
Figure 26: Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 27: Mexico Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 28: Mexico GDP and Population, 2017-2018 ($)
Figure 29: Mexico GDP – Composition of 2017, By Sector of Origin
Figure 30: Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 31: South America Life Sciences Artificial Intelligence (AI) Market South America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 32: Brazil Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 33: Brazil GDP and Population, 2017-2018 ($)
Figure 34: Brazil GDP – Composition of 2017, By Sector of Origin
Figure 35: Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 36: Venezuela Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 37: Venezuela GDP and Population, 2017-2018 ($)
Figure 38: Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 39: Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 40: Argentina Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 41: Argentina GDP and Population, 2017-2018 ($)
Figure 42: Argentina GDP – Composition of 2017, By Sector of Origin
Figure 43: Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 44: Ecuador Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 45: Ecuador GDP and Population, 2017-2018 ($)
Figure 46: Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 47: Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 48: Peru Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 49: Peru GDP and Population, 2017-2018 ($)
Figure 50: Peru GDP – Composition of 2017, By Sector of Origin
Figure 51: Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 52: Colombia Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 53: Colombia GDP and Population, 2017-2018 ($)
Figure 54: Colombia GDP – Composition of 2017, By Sector of Origin
Figure 55: Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 56: Costa Rica Life Sciences Artificial Intelligence (AI) Market Costa Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 57: Costa Rica GDP and Population, 2017-2018 ($)
Figure 58: Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 59: Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 60: Europe Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 61: U.K Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 62: U.K GDP and Population, 2017-2018 ($)
Figure 63: U.K GDP – Composition of 2017, By Sector of Origin
Figure 64: U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 65: Germany Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 66: Germany GDP and Population, 2017-2018 ($)
Figure 67: Germany GDP – Composition of 2017, By Sector of Origin
Figure 68: Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 69: Italy Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 70: Italy GDP and Population, 2017-2018 ($)
Figure 71: Italy GDP – Composition of 2017, By Sector of Origin
Figure 72: Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 73: France Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 74: France GDP and Population, 2017-2018 ($)
Figure 75: France GDP – Composition of 2017, By Sector of Origin
Figure 76: France Export and Import Value & Volume, 2017-2018 ($)
Figure 77: Netherlands Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 78: Netherlands GDP and Population, 2017-2018 ($)
Figure 79: Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 80: Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 81: Belgium Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 82: Belgium GDP and Population, 2017-2018 ($)
Figure 83: Belgium GDP – Composition of 2017, By Sector of Origin
Figure 84: Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 85: Spain Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 86: Spain GDP and Population, 2017-2018 ($)
Figure 87: Spain GDP – Composition of 2017, By Sector of Origin
Figure 88: Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 89: Denmark Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 90: Denmark GDP and Population, 2017-2018 ($)
Figure 91: Denmark GDP – Composition of 2017, By Sector of Origin
Figure 92: Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 93: APAC Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 94: China Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023
Figure 95: China GDP and Population, 2017-2018 ($)
Figure 96: China GDP – Composition of 2017, By Sector of Origin
Figure 97: China Export and Import Value & Volume, 2017-2018 ($)Life Sciences Artificial Intelligence (AI) Market China Export and Import Value & Volume, 2017-2018 ($)
Figure 98: Australia Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 99: Australia GDP and Population, 2017-2018 ($)
Figure 100: Australia GDP – Composition of 2017, By Sector of Origin
Figure 101: Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 102: South Korea Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 103: South Korea GDP and Population, 2017-2018 ($)
Figure 104: South Korea GDP – Composition of 2017, By Sector of Origin
Figure 105: South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 106: India Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 107: India GDP and Population, 2017-2018 ($)
Figure 108: India GDP – Composition of 2017, By Sector of Origin
Figure 109: India Export and Import Value & Volume, 2017-2018 ($)
Figure 110: Taiwan Life Sciences Artificial Intelligence (AI) Market Taiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 111: Taiwan GDP and Population, 2017-2018 ($)
Figure 112: Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 113: Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 114: Malaysia Life Sciences Artificial Intelligence (AI) Market Malaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 115: Malaysia GDP and Population, 2017-2018 ($)
Figure 116: Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 117: Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 118: Hong Kong Life Sciences Artificial Intelligence (AI) Market Hong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 119: Hong Kong GDP and Population, 2017-2018 ($)
Figure 120: Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 121: Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 122: Middle East & Africa Life Sciences Artificial Intelligence (AI) Market Middle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 123: Russia Life Sciences Artificial Intelligence (AI) Market Russia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 124: Russia GDP and Population, 2017-2018 ($)
Figure 125: Russia GDP – Composition of 2017, By Sector of Origin
Figure 126: Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 127: Israel Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2018-2023 ($)
Figure 128: Israel GDP and Population, 2017-2018 ($)
Figure 129: Israel GDP – Composition of 2017, By Sector of Origin
Figure 130: Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 131: Entropy Share, By Strategies, 2017-2018* (%)Life Sciences Artificial Intelligence (AI) Market 
Figure 132: Developments, 2017-2018*Life Sciences Artificial Intelligence (AI) Market 
Figure 133: Company 1 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2017-2018* ($)
Figure 134: Company 1 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 135: Company 1 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2017 (%)
Figure 136: Company 2 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2017-2018* ($)
Figure 137: Company 2 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 138: Company 2 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2017 (%)
Figure 139: Company 3 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2017-2018* ($)
Figure 140: Company 3 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 141: Company 3 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2017 (%)
Figure 142: Company 4 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2017-2018* ($)
Figure 143: Company 4 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 144: Company 4 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2017 (%)
Figure 145: Company 5 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2017-2018* ($)
Figure 146: Company 5 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 147: Company 5 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2017 (%)
Figure 148: Company 6 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2017-2018* ($)
Figure 149: Company 6 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 150: Company 6 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2017 (%)
Figure 151: Company 7 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2017-2018* ($)
Figure 152: Company 7 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 153: Company 7 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2017 (%)
Figure 154: Company 8 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2017-2018* ($)
Figure 155: Company 8 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 156: Company 8 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2017 (%)
Figure 157: Company 9 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2017-2018* ($)
Figure 158: Company 9 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 159: Company 9 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2017 (%)
Figure 160: Company 10 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2017-2018* ($)
Figure 161: Company 10 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 162: Company 10 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2017 (%)
Figure 163: Company 11 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2017-2018* ($)
Figure 164: Company 11 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 165: Company 11 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2017 (%)
Figure 166: Company 12 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2017-2018* ($)
Figure 167: Company 12 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 168: Company 12 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2017 (%)
Figure 169: Company 13 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2017-2018* ($)
Figure 170: Company 13 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 171: Company 13 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2017 (%)
Figure 172: Company 14 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2017-2018* ($)
Figure 173: Company 14 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 174: Company 14 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2017 (%)
Figure 175: Company 15 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2017-2018* ($)
Figure 176: Company 15 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 177: Company 15 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll